search
Back to results

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

Primary Purpose

Heart Failure

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Ziltivekimab
Placebo
Sponsored by
Novo Nordisk A/S
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Serum high-sensitivity C-reactive protein (hs-CRP) greater than equal to 2 milligrams per liter (mg/L) at screening (visit 1) Disease specific - cardiovascular At least one of the following: N-terminal-pro-brain natriuretic peptide (NT-proBNP) greater than equal to 300 picograms per milliliter (pg/mL) at screening (Visit 1) for patients without ongoing atrial fibrillation/flutter. If ongoing atrial fibrillation/flutter at screening (visit 1), NTproBNP must be greater than equal to 600 pg/mL. Hospitalisation or urgent/unplanned visit with a primary diagnosis of decompensated heart failure which required intravenous loop diuretic treatment, within the last 9 months prior to screening (visit 1) in combination with NT-proBNP greater than equal to 200 pg/mL at screening (Visit 1) for patients without ongoing atrial fibrillation/flutter. If ongoing atrial fibrillation/flutter at screening (visit 1), NT-proBNP must be greater than equal to 600 pg/mL. Diagnosis of heart failure (New York Heart Association [classification] [NYHA] Class II-IV). Left ventricular ejection fraction (LVEF) greater than 40 percentage (%) documented by echocardiography within 12 months prior to or at screening (visit 1). The LVEF must be documented in medical records and the most recent measurement must be used to determine eligibility with no interim event signalling potential deterioration in ejection fraction (e.g., myocardial infarction [MI] or heart failure [HF] hospitalisation). Structural heart disease and/or functional heart disease documented by echocardiography within 12 months prior to or at screening (visit 1) showing at least one of the following: Left atrial (LA) volume index greater than 34 milliliter per meter square (mL/m^2). LA diameter greater than equal to 3.8 centimeter (cm). LA length greater than equal to 5.0 cm. LA area greater than equal to 20 cm square. LA volume greater than equal to 55 milliters (mL). Intraventricular septal thickness greater than equal to 1.1 cm. Posterior wall thickness greater than equal to 1.1 cm. Left ventricular (LV) mass index greater than equal to 115 grams per meter square (g⁄m^2 ) in men or greater than equal to 95 g⁄m^2 in women. E/e' (mean septal and lateral) greater than equal to 10. e' (mean septal and lateral) less than 9 centimeter per second (cm/s). No heart failure hospitalisations or urgent heart failure visits between screening (visit 1) and randomisation (visit 2). Exclusion Criteria: Medical conditions - cardiovascular Myocardial infarction, stroke, unstable angina pectoris, transient ischaemic attack, or heart failure hospitalisation, within 30 days prior to screening (visit 1). Systolic blood pressure greater than equal to 180 millimeters of mercury (mmHg) at screening (visit 1). If the systolic blood pressure is 160-179 mmHg, the patient should be receiving greater than equal to 3 antihypertensive drugs. (Note: Potential participants may be retested for this criterion within the visit window and without rescreening, at the discretion of the investigator). Heart rate above 110 or below 40 beats per minute as evaluated on the electrocardiogram (ECG) performed at screening (visit 1) (Note: Potential participants may be retested for this criterion within the visit window and without rescreening, at the discretion of the investigator). Planned coronary, carotid or peripheral artery revascularisation known during the screening period (visit 1). (Note: Planned coronary angiogram is not exclusionary). Planned cardiac device or atrial flutter/atrial fibrillation ablation procedure known during the screening period (visit 1). Major cardiac surgical, non-cardiac surgical, or major endoscopic procedure (thoracoscopic or laparoscopic) within the past 60 days prior to randomisation (visit 2) or any major surgical procedure planned at the time of randomisation (visit 2). Heart failure due to infiltrative cardiomyopathy (e.g., sarcoid, amyloid), arrhythmogenic right ventricular cardiomyopathy, Takutsubo cardiomyopathy, genetic hypertrophic cardiomyopathy or obstructive cardiomyopathy, active myocarditis, constrictive pericarditis, cardiac tamponade, uncorrected more than moderate primary valve disease. Primary pulmonary hypertension, chronic pulmonary embolism, severe pulmonary disease including COPD. Any other condition judged by the investigator that could account for heart failure symptoms and signs (e.g., anaemia, hypothyroidism). Medical conditions - infections/immunosuppression - Clinical evidence of, or suspicion of, active infection at the discretion of the investigator.

Sites / Locations

  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational Site
  • Novo Nordisk Investigational SiteRecruiting
  • Novo Nordisk Investigational Site

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Ziltivekimab 15 mg

Placebo

Arm Description

Participants will receive ziltivekimab 15 milligrams (mg) subcutaneous (s.c.) injection once-monthly and added to standard of care for up to 4 years.

Participants will receive ziltivekimab placebo subcutaneous (s.c.) injection once-monthly and added to standard of care for up to 4 years.

Outcomes

Primary Outcome Measures

Time to First Occurrence of a Composite Heart Failure Endpoint Consisting of: Cardiovascular (CV) Death, Heart Failure (HF) Hospitalisation or Urgent HF Visit
Measured in months.

Secondary Outcome Measures

Time to First Occurrence of 4-point Expanded Composite HF Endpoint, a Composite Endpoint Consisting of: CV Death, HF Hospitalisation or Urgent HF Visit, Non-fatal Myocardial Infarction (MI), Non-fatal Stroke
Measured in months.
Number of CV Deaths, HF Hospitalisations or Urgent HF Visits (First and Recurrent)
Measured as count of event.
Time to Occurrence of CV Death
Measured in months.
Time to Occurrence of all-cause Death
Measured in months.
Time to First Occurrence of 4-point Expanded Composite HF Endpoint, a Composite Endpoint Consisting of: All-cause Death, HF Hospitalisation or Urgent HF Visit, Non-fatal MI, Non-fatal stroke
Measured in months.
Hierarchical Composite of: Time to All-cause Death, Number of HF Hospitalisations or Urgent HF Visits, Time to First HF Hospitalisation or Urgent HF Visit, difference of at least 5 in KCCQ clinical summary score change from baseline to 12 months
Kansas City Cardiomyopathy Questionnaire (KCCQ) measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as total wins for each treatment group.
Time to First Occurrence of HF Hospitalisation or Urgent HF Visit
Measured in months.
Number of Events of Atrial Fibrillation
Measured as count of event.
Change in KCCQ Clinical Summary Score
KCCQ measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as score.
Improvement of 5 Points or More in KCCQ Clinical Summary Score (Yes/No)
Kansas City Cardiomyopathy Questionnaire (KCCQ) measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as count of participant.
Improvement of 10 Points or More in KCCQ Clinical Summary Score (Yes/No)
Kansas City Cardiomyopathy Questionnaire (KCCQ) measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as count of participant.
Improvement in New York Heart Association (Classification) [NYHA Class] (Yes/No)
NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I: Participant with cardiac disease but without resulting limitations of physical activity. Class II: Participants with cardiac disease resulting in slight limitation of physical activity. Class III: Participants with cardiac disease resulting in marked limitation of physical activity. Class IV: Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort. Measured as count of participant.
Time to First Occurrence of a Composite Chronic Kidney Disease (CKD) Endpoint Consisting of: CV death, Onset of Persistent Greater Than Equal To 40 Percentage Reduction in eGFR (CKD- EPI) compared with baseline; Kidney failure
eGFR = estimated glomerular filtration rate; CKD-EPI = chronic kidney disease - epidemiology collaboration. Kidney failure defined as: death from kidney failure, onset of persistent eGFR less than 15 milliliters per minute (mL/min)/1.73 meter square (m^2) (CKD-EPI), initiation of chronic kidney replacement therapy (maintenance dialysis or kidney transplantation). Measured in months.
Change in Estimated Glomerular Filtration Rate (eGFR) (Chronic Kidney Disease - Epidemiology Collaboration [CKD-EPI])
Measured as mL/min/1.73 m^2.
Annual Rate of Change in eGFR (CKD-EPI) (Total eGFR Slope)
Measured as mL/min/1.73 m^2/year.
Number of Hospitalisations With Infection as Primary Cause or Death Due to Infection
Measured as count of event.
Change in High-sensitivity C-reactive Protein (hs-CRP)
Measured as ratio to baseline.
Change in N-terminal-pro-brain Natriuretic Peptide (NT-proBNP)
Measured as ratio to baseline.

Full Information

First Posted
November 23, 2022
Last Updated
October 18, 2023
Sponsor
Novo Nordisk A/S
search

1. Study Identification

Unique Protocol Identification Number
NCT05636176
Brief Title
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Acronym
HERMES
Official Title
HERMES: Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 8, 2023 (Actual)
Primary Completion Date
July 2, 2027 (Anticipated)
Study Completion Date
July 2, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Novo Nordisk A/S

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get ziltivekimab or placebo. The study is expected to last for up to 4 years. Participants will have up to 20 clinic visits. Participants will have to use a study app on their phone to record and share information about all their injections of study medicine and to fill in questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
5600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Ziltivekimab 15 mg
Arm Type
Experimental
Arm Description
Participants will receive ziltivekimab 15 milligrams (mg) subcutaneous (s.c.) injection once-monthly and added to standard of care for up to 4 years.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Participants will receive ziltivekimab placebo subcutaneous (s.c.) injection once-monthly and added to standard of care for up to 4 years.
Intervention Type
Drug
Intervention Name(s)
Ziltivekimab
Intervention Description
Participants will receive ziltivekimab 15 milligrams (mg) subcutaneous (s.c.) injection once-monthly and added to standard of care for up to 4 years.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Participants will receive ziltivekimab placebo subcutaneous (s.c.) injection once-monthly and added to standard of care for up to 4 years.
Primary Outcome Measure Information:
Title
Time to First Occurrence of a Composite Heart Failure Endpoint Consisting of: Cardiovascular (CV) Death, Heart Failure (HF) Hospitalisation or Urgent HF Visit
Description
Measured in months.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Secondary Outcome Measure Information:
Title
Time to First Occurrence of 4-point Expanded Composite HF Endpoint, a Composite Endpoint Consisting of: CV Death, HF Hospitalisation or Urgent HF Visit, Non-fatal Myocardial Infarction (MI), Non-fatal Stroke
Description
Measured in months.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Number of CV Deaths, HF Hospitalisations or Urgent HF Visits (First and Recurrent)
Description
Measured as count of event.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Time to Occurrence of CV Death
Description
Measured in months.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Time to Occurrence of all-cause Death
Description
Measured in months.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Time to First Occurrence of 4-point Expanded Composite HF Endpoint, a Composite Endpoint Consisting of: All-cause Death, HF Hospitalisation or Urgent HF Visit, Non-fatal MI, Non-fatal stroke
Description
Measured in months.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Hierarchical Composite of: Time to All-cause Death, Number of HF Hospitalisations or Urgent HF Visits, Time to First HF Hospitalisation or Urgent HF Visit, difference of at least 5 in KCCQ clinical summary score change from baseline to 12 months
Description
Kansas City Cardiomyopathy Questionnaire (KCCQ) measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as total wins for each treatment group.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Time to First Occurrence of HF Hospitalisation or Urgent HF Visit
Description
Measured in months.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Number of Events of Atrial Fibrillation
Description
Measured as count of event.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Change in KCCQ Clinical Summary Score
Description
KCCQ measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as score.
Time Frame
From randomisation (month 0) to 12 months
Title
Improvement of 5 Points or More in KCCQ Clinical Summary Score (Yes/No)
Description
Kansas City Cardiomyopathy Questionnaire (KCCQ) measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as count of participant.
Time Frame
From randomisation (month 0) to 12 months
Title
Improvement of 10 Points or More in KCCQ Clinical Summary Score (Yes/No)
Description
Kansas City Cardiomyopathy Questionnaire (KCCQ) measures Health-Related Quality of Life (HRQOL) and is a disease-specific health status instrument for HF. Score ranges from 0 to 100, with 0 as the lowest score and 100 as the highest score. Higher scores indicate better health status, fewer symptoms, and greater disease-specific health related quality of life, respectively. Measured as count of participant.
Time Frame
From randomisation (month 0) to 12 months
Title
Improvement in New York Heart Association (Classification) [NYHA Class] (Yes/No)
Description
NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA) Class I: Participant with cardiac disease but without resulting limitations of physical activity. Class II: Participants with cardiac disease resulting in slight limitation of physical activity. Class III: Participants with cardiac disease resulting in marked limitation of physical activity. Class IV: Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort. Measured as count of participant.
Time Frame
From randomisation (month 0) to 12 months
Title
Time to First Occurrence of a Composite Chronic Kidney Disease (CKD) Endpoint Consisting of: CV death, Onset of Persistent Greater Than Equal To 40 Percentage Reduction in eGFR (CKD- EPI) compared with baseline; Kidney failure
Description
eGFR = estimated glomerular filtration rate; CKD-EPI = chronic kidney disease - epidemiology collaboration. Kidney failure defined as: death from kidney failure, onset of persistent eGFR less than 15 milliliters per minute (mL/min)/1.73 meter square (m^2) (CKD-EPI), initiation of chronic kidney replacement therapy (maintenance dialysis or kidney transplantation). Measured in months.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Change in Estimated Glomerular Filtration Rate (eGFR) (Chronic Kidney Disease - Epidemiology Collaboration [CKD-EPI])
Description
Measured as mL/min/1.73 m^2.
Time Frame
From randomisation (month 0) to 12 months
Title
Annual Rate of Change in eGFR (CKD-EPI) (Total eGFR Slope)
Description
Measured as mL/min/1.73 m^2/year.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Number of Hospitalisations With Infection as Primary Cause or Death Due to Infection
Description
Measured as count of event.
Time Frame
From randomisation (month 0) to end of study (up to 48 months)
Title
Change in High-sensitivity C-reactive Protein (hs-CRP)
Description
Measured as ratio to baseline.
Time Frame
From randomisation (month 0) to 12 months
Title
Change in N-terminal-pro-brain Natriuretic Peptide (NT-proBNP)
Description
Measured as ratio to baseline.
Time Frame
From randomisation (month 0) to 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Serum high-sensitivity C-reactive protein (hs-CRP) greater than equal to 2 milligrams per liter (mg/L) at screening (visit 1) Disease specific - cardiovascular At least one of the following: N-terminal-pro-brain natriuretic peptide (NT-proBNP) greater than equal to 300 picograms per milliliter (pg/mL) at screening (Visit 1) for patients without ongoing atrial fibrillation/flutter. If ongoing atrial fibrillation/flutter at screening (visit 1), NTproBNP must be greater than equal to 600 pg/mL. Hospitalisation or urgent/unplanned visit with a primary diagnosis of decompensated heart failure which required intravenous loop diuretic treatment, within the last 9 months prior to screening (visit 1) in combination with NT-proBNP greater than equal to 200 pg/mL at screening (Visit 1) for patients without ongoing atrial fibrillation/flutter. If ongoing atrial fibrillation/flutter at screening (visit 1), NT-proBNP must be greater than equal to 600 pg/mL. Diagnosis of heart failure (New York Heart Association [classification] [NYHA] Class II-IV). Left ventricular ejection fraction (LVEF) greater than 40 percentage (%) documented by echocardiography within 12 months prior to or at screening (visit 1). The LVEF must be documented in medical records and the most recent measurement must be used to determine eligibility with no interim event signalling potential deterioration in ejection fraction (e.g., myocardial infarction [MI] or heart failure [HF] hospitalisation). Structural heart disease and/or functional heart disease documented by echocardiography within 12 months prior to or at screening (visit 1) showing at least one of the following: Left atrial (LA) volume index greater than 34 milliliter per meter square (mL/m^2). LA diameter greater than equal to 3.8 centimeter (cm). LA length greater than equal to 5.0 cm. LA area greater than equal to 20 cm square. LA volume greater than equal to 55 milliters (mL). Intraventricular septal thickness greater than equal to 1.1 cm. Posterior wall thickness greater than equal to 1.1 cm. Left ventricular (LV) mass index greater than equal to 115 grams per meter square (g⁄m^2 ) in men or greater than equal to 95 g⁄m^2 in women. E/e' (mean septal and lateral) greater than equal to 10. e' (mean septal and lateral) less than 9 centimeter per second (cm/s). No heart failure hospitalisations or urgent heart failure visits between screening (visit 1) and randomisation (visit 2). Exclusion Criteria: Medical conditions - cardiovascular Myocardial infarction, stroke, unstable angina pectoris, transient ischaemic attack, or heart failure hospitalisation, within 30 days prior to screening (visit 1). Systolic blood pressure greater than equal to 180 millimeters of mercury (mmHg) at screening (visit 1). If the systolic blood pressure is 160-179 mmHg, the patient should be receiving greater than equal to 3 antihypertensive drugs. (Note: Potential participants may be retested for this criterion within the visit window and without rescreening, at the discretion of the investigator). Heart rate above 110 or below 40 beats per minute as evaluated on the electrocardiogram (ECG) performed at screening (visit 1) (Note: Potential participants may be retested for this criterion within the visit window and without rescreening, at the discretion of the investigator). Planned coronary, carotid or peripheral artery revascularisation known during the screening period (visit 1). (Note: Planned coronary angiogram is not exclusionary). Planned cardiac device or atrial flutter/atrial fibrillation ablation procedure known during the screening period (visit 1). Major cardiac surgical, non-cardiac surgical, or major endoscopic procedure (thoracoscopic or laparoscopic) within the past 60 days prior to randomisation (visit 2) or any major surgical procedure planned at the time of randomisation (visit 2). Heart failure due to infiltrative cardiomyopathy (e.g., sarcoid, amyloid), arrhythmogenic right ventricular cardiomyopathy, Takutsubo cardiomyopathy, genetic hypertrophic cardiomyopathy or obstructive cardiomyopathy, active myocarditis, constrictive pericarditis, cardiac tamponade, uncorrected more than moderate primary valve disease. Primary pulmonary hypertension, chronic pulmonary embolism, severe pulmonary disease including COPD. Any other condition judged by the investigator that could account for heart failure symptoms and signs (e.g., anaemia, hypothyroidism). Medical conditions - infections/immunosuppression - Clinical evidence of, or suspicion of, active infection at the discretion of the investigator.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Novo Nordisk
Phone
(+1) 866-867-7178
Email
clinicaltrials@novonordisk.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clinical Transparency (dept. 2834)
Organizational Affiliation
Novo Nordisk A/S
Official's Role
Study Director
Facility Information:
Facility Name
Novo Nordisk Investigational Site
City
Alexander City
State/Province
Alabama
ZIP/Postal Code
35010
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Fairhope
State/Province
Alabama
ZIP/Postal Code
36532
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Huntsville
State/Province
Alabama
ZIP/Postal Code
35801
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85006
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72204
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90211
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Covina
State/Province
California
ZIP/Postal Code
91723
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
La Jolla
State/Province
California
ZIP/Postal Code
90237
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
La Mesa
State/Province
California
ZIP/Postal Code
91942
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Loma Linda
State/Province
California
ZIP/Postal Code
92357
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90073
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Northridge
State/Province
California
ZIP/Postal Code
91325
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Palo Alto
State/Province
California
ZIP/Postal Code
94304
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
San Diego
State/Province
California
ZIP/Postal Code
92123
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
San Dimas
State/Province
California
ZIP/Postal Code
91773
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Torrance
State/Province
California
ZIP/Postal Code
90502
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Van Nuys
State/Province
California
ZIP/Postal Code
91405
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Littleton
State/Province
Colorado
ZIP/Postal Code
80120
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Bridgeport
State/Province
Connecticut
ZIP/Postal Code
06610
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Stamford
State/Province
Connecticut
ZIP/Postal Code
06905
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Crystal River
State/Province
Florida
ZIP/Postal Code
34429
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33021
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32204
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32216
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32258
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33133
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Naples
State/Province
Florida
ZIP/Postal Code
34102
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
North Miami Beach
State/Province
Florida
ZIP/Postal Code
33169
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ocala
State/Province
Florida
ZIP/Postal Code
34471
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint Augustine
State/Province
Florida
ZIP/Postal Code
32086
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wellington
State/Province
Florida
ZIP/Postal Code
33449
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Winter Haven
State/Province
Florida
ZIP/Postal Code
33881
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30310
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Johns Creek
State/Province
Georgia
ZIP/Postal Code
30024
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Macon
State/Province
Georgia
ZIP/Postal Code
31201
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96817
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Meridian
State/Province
Idaho
ZIP/Postal Code
83642
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Arlington Heights
State/Province
Illinois
ZIP/Postal Code
60005
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Downers Grove
State/Province
Illinois
ZIP/Postal Code
60515
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hazel Crest
State/Province
Illinois
ZIP/Postal Code
60429
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Naperville
State/Province
Illinois
ZIP/Postal Code
60540
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Peoria
State/Province
Illinois
ZIP/Postal Code
61614
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Peoria
State/Province
Illinois
ZIP/Postal Code
61636
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Elkhart
State/Province
Indiana
ZIP/Postal Code
46514
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hammond
State/Province
Indiana
ZIP/Postal Code
46324
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46237
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lebanon
State/Province
Indiana
ZIP/Postal Code
46052
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Munster
State/Province
Indiana
ZIP/Postal Code
46321
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Richmond
State/Province
Indiana
ZIP/Postal Code
47374
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66211
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66211
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Elizabethtown
State/Province
Kentucky
ZIP/Postal Code
42701
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40503
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40206
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40207
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Alexandria
State/Province
Louisiana
ZIP/Postal Code
71301
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bogalusa
State/Province
Louisiana
ZIP/Postal Code
70427
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hammond
State/Province
Louisiana
ZIP/Postal Code
70403
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70112
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21229
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21287
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lanham
State/Province
Maryland
ZIP/Postal Code
20706
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Oxon Hill
State/Province
Maryland
ZIP/Postal Code
20745
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Haverhill
State/Province
Massachusetts
ZIP/Postal Code
01830
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48106
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Flint
State/Province
Michigan
ZIP/Postal Code
48532
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Grand Rapids
State/Province
Michigan
ZIP/Postal Code
49546
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ypsilanti
State/Province
Michigan
ZIP/Postal Code
48197
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Maplewood
State/Province
Minnesota
ZIP/Postal Code
55109
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Maplewood
State/Province
Minnesota
ZIP/Postal Code
55109
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55417
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tupelo
State/Province
Mississippi
ZIP/Postal Code
38801
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63136
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kalispell
State/Province
Montana
ZIP/Postal Code
59901
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68198
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bridgewater
State/Province
New Jersey
ZIP/Postal Code
08807-3064
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Elmer
State/Province
New Jersey
ZIP/Postal Code
08318
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Linden
State/Province
New Jersey
ZIP/Postal Code
07036
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Linden
State/Province
New Jersey
ZIP/Postal Code
07036
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mullica Hill
State/Province
New Jersey
ZIP/Postal Code
08062
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Newark
State/Province
New Jersey
ZIP/Postal Code
07102
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ridgewood
State/Province
New Jersey
ZIP/Postal Code
07450
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Ridgewood
State/Province
New Jersey
ZIP/Postal Code
07450
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Albany
State/Province
New York
ZIP/Postal Code
12211
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bronx
State/Province
New York
ZIP/Postal Code
10455
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Buffalo
State/Province
New York
ZIP/Postal Code
14215
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Kew Gardens
State/Province
New York
ZIP/Postal Code
11415
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10019
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
New York
State/Province
New York
ZIP/Postal Code
10035
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rosedale
State/Province
New York
ZIP/Postal Code
11422
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rosedale
State/Province
New York
ZIP/Postal Code
11422
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saratoga Springs
State/Province
New York
ZIP/Postal Code
12866
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Stony Brook
State/Province
New York
ZIP/Postal Code
11794
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27405
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lumberton
State/Province
North Carolina
ZIP/Postal Code
28358
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Morehead City
State/Province
North Carolina
ZIP/Postal Code
28557
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27607
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Canton
State/Province
Ohio
ZIP/Postal Code
44710
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Marion
State/Province
Ohio
ZIP/Postal Code
43302
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73135
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Camp Hill
State/Province
Pennsylvania
ZIP/Postal Code
17011
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Danville
State/Province
Pennsylvania
ZIP/Postal Code
17822
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lancaster
State/Province
Pennsylvania
ZIP/Postal Code
17603
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19114
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15212
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Wyomissing
State/Province
Pennsylvania
ZIP/Postal Code
19610
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29203
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57701
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sioux Falls
State/Province
South Dakota
ZIP/Postal Code
57117
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jackson
State/Province
Tennessee
ZIP/Postal Code
38301
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Knoxville
State/Province
Tennessee
ZIP/Postal Code
37934
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Allen
State/Province
Texas
ZIP/Postal Code
75013
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Amarillo
State/Province
Texas
ZIP/Postal Code
79109
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
El Paso
State/Province
Texas
ZIP/Postal Code
79905
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77025
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77070
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
McKinney
State/Province
Texas
ZIP/Postal Code
75071
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78212
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sherman
State/Province
Texas
ZIP/Postal Code
75092
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Burlington
State/Province
Vermont
ZIP/Postal Code
05401
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Charlottesville
State/Province
Virginia
ZIP/Postal Code
22908
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chesterfield
State/Province
Virginia
ZIP/Postal Code
23832
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Falls Church
State/Province
Virginia
ZIP/Postal Code
22042
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Manassas
State/Province
Virginia
ZIP/Postal Code
20109
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23504
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23507
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23298
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Roanoke
State/Province
Virginia
ZIP/Postal Code
24014
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Salem
State/Province
Virginia
ZIP/Postal Code
24153-6404
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Winchester
State/Province
Virginia
ZIP/Postal Code
22601-3834
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seattle
State/Province
Washington
ZIP/Postal Code
98122-5789
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99204
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26506
Country
United States
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53705
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53215
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Caba
State/Province
Buenos Aires
ZIP/Postal Code
C1128 AAF
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Granadero Baigorria
State/Province
Santa Fe
ZIP/Postal Code
2152
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Buenos Aires
ZIP/Postal Code
B1704ETD
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Buenos Aires
ZIP/Postal Code
C1181ACH
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Caba
ZIP/Postal Code
C1093AAS
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Caba
ZIP/Postal Code
C1093AAS
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Caba
ZIP/Postal Code
C1440CFD
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Corrientes
ZIP/Postal Code
W3400AMZ
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Corrientes
ZIP/Postal Code
W3400AMZ
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mar del Plata
ZIP/Postal Code
B7600FZN
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mar del Plata
ZIP/Postal Code
B7600GNY
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
San Nicolás
ZIP/Postal Code
B2900
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Santa Fe
ZIP/Postal Code
3000
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Garran
State/Province
Australian Capital Territory
ZIP/Postal Code
2605
Country
Australia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Concord
State/Province
New South Wales
ZIP/Postal Code
2139
Country
Australia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Gosford
State/Province
New South Wales
ZIP/Postal Code
2250
Country
Australia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Adelaide
State/Province
South Australia
ZIP/Postal Code
5000
Country
Australia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bedford Park
State/Province
South Australia
ZIP/Postal Code
5042
Country
Australia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hobart
State/Province
Tasmania
ZIP/Postal Code
7000
Country
Australia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Frankston
State/Province
Victoria
ZIP/Postal Code
3199
Country
Australia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Geelong
State/Province
Victoria
ZIP/Postal Code
3220
Country
Australia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Brisbane
ZIP/Postal Code
4029
Country
Australia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Braunau
ZIP/Postal Code
A 5280
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Graz
ZIP/Postal Code
A 8036
Country
Austria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Graz
ZIP/Postal Code
A 8036
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint Stefan
ZIP/Postal Code
8511
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vienna
ZIP/Postal Code
1090
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vienna
ZIP/Postal Code
1160
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wien
ZIP/Postal Code
1100
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wien
ZIP/Postal Code
A 1190
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aalst
ZIP/Postal Code
9300
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Brussel
ZIP/Postal Code
1090
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Edegem
ZIP/Postal Code
2650
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Genk
ZIP/Postal Code
3600
Country
Belgium
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kortrijk
ZIP/Postal Code
8500
Country
Belgium
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Liège
ZIP/Postal Code
4000
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Banja Luka
ZIP/Postal Code
78000
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sarajevo
ZIP/Postal Code
71000
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sarajevo
ZIP/Postal Code
71000
Country
Bosnia and Herzegovina
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vitória
State/Province
Espirito Santo
ZIP/Postal Code
29055-450
Country
Brazil
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Belo Horizonte
State/Province
Minas Gerais
ZIP/Postal Code
30150-320
Country
Brazil
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90035-003
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Campinas
State/Province
Sao Paulo
ZIP/Postal Code
13059-740
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Campinas
State/Province
Sao Paulo
ZIP/Postal Code
13060-080
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Campinas
State/Province
Sao Paulo
ZIP/Postal Code
13092-133
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
São José do Rio Preto
State/Province
Sao Paulo
ZIP/Postal Code
15090-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cidade Nova Votuporanga
State/Province
São Paulo
ZIP/Postal Code
15501-405
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aracaju
ZIP/Postal Code
49055-530
Country
Brazil
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Belo Horizonte/MG
ZIP/Postal Code
30220-140
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Goiânia/GO
ZIP/Postal Code
74605-020
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Marília/SP
ZIP/Postal Code
17515-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Porto Alegre/RS
ZIP/Postal Code
90840-440
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Recife/PE
ZIP/Postal Code
56517-630
Country
Brazil
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Ribeirão Preto/SP
ZIP/Postal Code
14051-140
Country
Brazil
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Rio de Janeiro
ZIP/Postal Code
22061-080
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rio de Janeiro
ZIP/Postal Code
22281-100
Country
Brazil
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
São Paulo/SP
ZIP/Postal Code
04026-090
Country
Brazil
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Burgas
ZIP/Postal Code
8000
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kozloduy
ZIP/Postal Code
3320
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lom
ZIP/Postal Code
3600
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Panagyurishte
ZIP/Postal Code
4500
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pleven
ZIP/Postal Code
5800
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Plovdiv
ZIP/Postal Code
4002
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sandanski
ZIP/Postal Code
2800
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sevlievo
ZIP/Postal Code
5400
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sofia
ZIP/Postal Code
1202
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sofia
ZIP/Postal Code
1233
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sofia
ZIP/Postal Code
1431
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sofia
ZIP/Postal Code
1527
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Stara Zagora
ZIP/Postal Code
6000
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Veliko Tarnovo
ZIP/Postal Code
5000
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N 4Z6
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5A 4L8
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Westminster
State/Province
British Columbia
ZIP/Postal Code
V3L 3W4
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
North Vancouver
State/Province
British Columbia
ZIP/Postal Code
V7M 2H4
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
North Vancouver
State/Province
British Columbia
ZIP/Postal Code
V7M 2H4
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Surrey
State/Province
British Columbia
ZIP/Postal Code
V2V 0C6
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z 1M9
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V6Z1Y6
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Victoria
State/Province
British Columbia
ZIP/Postal Code
V8R 1B2
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R2H 2HA6
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Moncton
State/Province
New Brunswick
ZIP/Postal Code
E1G 1A7
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 3A7
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cambridge
State/Province
Ontario
ZIP/Postal Code
N1R 6V6
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cambridge
State/Province
Ontario
ZIP/Postal Code
N1R7R1
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Guelph
State/Province
Ontario
ZIP/Postal Code
N1H 1B1
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8L 2X2
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 4V2
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Newmarket
State/Province
Ontario
ZIP/Postal Code
L3Y 2P6
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
North York
State/Province
Ontario
ZIP/Postal Code
M6B 3H7
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Oshawa
State/Province
Ontario
ZIP/Postal Code
L1J 2K9
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Peterborough
State/Province
Ontario
ZIP/Postal Code
K9J 0B2
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sudbury
State/Province
Ontario
ZIP/Postal Code
P3E 5J1
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5S 1B1
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M6G 1M2
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Waterloo
State/Province
Ontario
ZIP/Postal Code
N2T 0C1
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Winchester
State/Province
Ontario
ZIP/Postal Code
K0C 2K0
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Brossard
State/Province
Quebec
ZIP/Postal Code
J4Z-2K9
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H1T 1C8
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Montréal
State/Province
Quebec
ZIP/Postal Code
H2X 0C1
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sherbrooke
State/Province
Quebec
ZIP/Postal Code
J1G 2E8
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
St. Jean sur Richelieu
State/Province
Quebec
ZIP/Postal Code
J3A 1J2
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Terrebonne
State/Province
Quebec
ZIP/Postal Code
J6V 2H2
Country
Canada
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Terrebonne
State/Province
Quebec
ZIP/Postal Code
J6X 4P7
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Trois-Rivières
State/Province
Quebec
ZIP/Postal Code
G9A 4P3
Country
Canada
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saskatoon
State/Province
Saskatchewan
ZIP/Postal Code
S7N 0W8
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100029
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chongqing
State/Province
Chongqing
ZIP/Postal Code
404000
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lanzhou
State/Province
Gansu
ZIP/Postal Code
730030
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510120
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510630
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shenzhen
State/Province
Guangdong
ZIP/Postal Code
518020
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Haikou
State/Province
Hainan
ZIP/Postal Code
570311
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shijiazhuang
State/Province
Hebei
ZIP/Postal Code
050051
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wuhan
State/Province
Hubei
ZIP/Postal Code
430060
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Changzhou
State/Province
Jiangsu
ZIP/Postal Code
213003
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Huai'an
State/Province
Jiangsu
ZIP/Postal Code
223300
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210011
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Suzhou
State/Province
Jiangsu
ZIP/Postal Code
215000
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Yangzhou
State/Province
Jiangsu
ZIP/Postal Code
225001
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zhenjiang
State/Province
Jiangsu
ZIP/Postal Code
212001
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Changchun
State/Province
Jilin
ZIP/Postal Code
130033
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Siping
State/Province
Jilin
ZIP/Postal Code
136000
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shenyang
State/Province
Liaoning
ZIP/Postal Code
110016
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Yinchuan
State/Province
Ningxia
ZIP/Postal Code
750004
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710068
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200065
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310003
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310014
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lishui
State/Province
Zhejiang
ZIP/Postal Code
323000
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wenzhou
State/Province
Zhejiang
ZIP/Postal Code
325000
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Anhui/huainan
ZIP/Postal Code
232007
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Changsha
ZIP/Postal Code
410013
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Changsha
ZIP/Postal Code
410028
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ha Erbin
ZIP/Postal Code
150001
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jingan/Shanghai
ZIP/Postal Code
200040
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nanjing
ZIP/Postal Code
210009
Country
China
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Nanning
ZIP/Postal Code
530021
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shanghai
ZIP/Postal Code
20031
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tianjin
ZIP/Postal Code
300222
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Xi'an
ZIP/Postal Code
710061
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Medellin
State/Province
Antioquia
ZIP/Postal Code
050015
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Medellin
State/Province
Antioquia
ZIP/Postal Code
050030
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Barranquilla
State/Province
Atlántico
ZIP/Postal Code
080001
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Soledad
State/Province
Barranquilla
ZIP/Postal Code
83001
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Manizales
State/Province
Caldas
ZIP/Postal Code
170003
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucaramanga-piedecuesta, Valle Del Menzuli - Santander
State/Province
Santander
ZIP/Postal Code
681012
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Barranquilla
ZIP/Postal Code
080020
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Barranquilla
ZIP/Postal Code
80020
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cali
ZIP/Postal Code
760042
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Medellin
ZIP/Postal Code
050021
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Medellin
ZIP/Postal Code
050034
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zagreb
State/Province
Grad Zagreb
ZIP/Postal Code
10 000
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zagreb
State/Province
Grad Zagreb
ZIP/Postal Code
10 000
Country
Croatia
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Zagreb
State/Province
Grad Zagreb
ZIP/Postal Code
10000
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zagreb
State/Province
Grad Zagreb
ZIP/Postal Code
10000
Country
Croatia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Krapinske Toplice
State/Province
Krapinsko Zagorska County
ZIP/Postal Code
49217
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cakovec
ZIP/Postal Code
40000
Country
Croatia
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Karlovac
ZIP/Postal Code
47000
Country
Croatia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osijek
ZIP/Postal Code
31000
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rijeka
ZIP/Postal Code
51000
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Split
ZIP/Postal Code
21000
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zagreb
ZIP/Postal Code
10 000
Country
Croatia
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Zagreb
ZIP/Postal Code
10040
Country
Croatia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hradec Kralove
ZIP/Postal Code
50005
Country
Czechia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Liberec
ZIP/Postal Code
460 02
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Plzen - Lochotín
ZIP/Postal Code
323 00
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Policka
ZIP/Postal Code
572 01
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Praha 1
ZIP/Postal Code
110 00
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Praha 1
ZIP/Postal Code
110 00
Country
Czechia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Praha 2
ZIP/Postal Code
120 00
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Slany
ZIP/Postal Code
274 01
Country
Czechia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tabor
ZIP/Postal Code
39003
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tabor
ZIP/Postal Code
39003
Country
Czechia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Trutnov
ZIP/Postal Code
541 01
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Uherske Hradiste
ZIP/Postal Code
68601
Country
Czechia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Herlev
State/Province
Region Hovedstaden
ZIP/Postal Code
2730
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Svendborg
State/Province
Region South
ZIP/Postal Code
5700
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aarhus N
ZIP/Postal Code
8200
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Frederiksberg
ZIP/Postal Code
2000
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Roskilde
ZIP/Postal Code
4000
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tallinn
ZIP/Postal Code
10138
Country
Estonia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tallinn
ZIP/Postal Code
13419
Country
Estonia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tartu
ZIP/Postal Code
50406
Country
Estonia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jyväskylä
ZIP/Postal Code
40620
Country
Finland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kuopio
ZIP/Postal Code
70210
Country
Finland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seinäjoki
ZIP/Postal Code
60220
Country
Finland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tampere
ZIP/Postal Code
33520
Country
Finland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Turku
ZIP/Postal Code
20520
Country
Finland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
La Tronche
ZIP/Postal Code
38700
Country
France
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Montpellier
ZIP/Postal Code
34295
Country
France
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Paris
ZIP/Postal Code
75010
Country
France
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Paris
ZIP/Postal Code
75013
Country
France
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Poitiers
ZIP/Postal Code
86000
Country
France
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Poitiers
ZIP/Postal Code
86000
Country
France
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Toulouse
ZIP/Postal Code
31059
Country
France
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aachen
ZIP/Postal Code
52074
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Berlin
ZIP/Postal Code
10787
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Berlin
ZIP/Postal Code
13353
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bremen
ZIP/Postal Code
28277
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dortmund
ZIP/Postal Code
44137
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dresden
ZIP/Postal Code
01277
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dresden
ZIP/Postal Code
01307
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Elsterwerda
ZIP/Postal Code
04910
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Frankfurt
ZIP/Postal Code
60389
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Freiburg
ZIP/Postal Code
79106
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Giessen
ZIP/Postal Code
35392
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Göttingen
ZIP/Postal Code
37075
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hamburg
ZIP/Postal Code
20251
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hassloch
ZIP/Postal Code
67454
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Homburg
ZIP/Postal Code
66421
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jena
ZIP/Postal Code
07747
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kaiserslautern
ZIP/Postal Code
67655
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Leipzig
ZIP/Postal Code
04103
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mannheim
ZIP/Postal Code
68165
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
München
ZIP/Postal Code
81377
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Papenburg
ZIP/Postal Code
26871
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wermsdorf
ZIP/Postal Code
04779
Country
Germany
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Würzburg
ZIP/Postal Code
97078
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Athens
State/Province
Attiki
ZIP/Postal Code
GR11528
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Heraklion
State/Province
Crete
ZIP/Postal Code
GR-71500
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Athens
ZIP/Postal Code
11527
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Athens
ZIP/Postal Code
GR-11527
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Athens
ZIP/Postal Code
GR-11527
Country
Greece
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Athens
ZIP/Postal Code
GR-14233
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Athens
ZIP/Postal Code
GR-15123
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Athens
ZIP/Postal Code
GR-15125
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chaidari, Athens
ZIP/Postal Code
GR-12462
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chios
ZIP/Postal Code
GR82100
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Larissa
ZIP/Postal Code
GR-41110
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pylea, Thessaloniki
ZIP/Postal Code
GR-57001
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rio Patras
ZIP/Postal Code
GR26504
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Thessaloniki
ZIP/Postal Code
54635
Country
Greece
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Thessaloniki
ZIP/Postal Code
54636
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Thessaloniki
ZIP/Postal Code
54636
Country
Greece
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Thessaloniki
ZIP/Postal Code
GR54642
Country
Greece
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pécs
State/Province
Baranya Megye
ZIP/Postal Code
7624
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Baja
State/Province
Bács-Kiskun
ZIP/Postal Code
6500
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Békéscsaba
State/Province
Békés Megye
ZIP/Postal Code
5600
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Orosháza
State/Province
Békés Megye
ZIP/Postal Code
5900
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Szeged
State/Province
Csongrád-Csanád
ZIP/Postal Code
6725
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Komárom
State/Province
Komárom-Esztergom
ZIP/Postal Code
2921
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kaposvár
State/Province
Somogy Megye
ZIP/Postal Code
7400
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zalaegerszeg
State/Province
Zala Megye
ZIP/Postal Code
8900
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1096
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1122
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1204
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Guntur
State/Province
Andhra Pradesh
ZIP/Postal Code
522001
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hyderabad
State/Province
Andhra Pradesh
ZIP/Postal Code
500020
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vijayawada
State/Province
Andhra Pradesh
ZIP/Postal Code
520008
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110002
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ahmedabad
State/Province
Gujarat
ZIP/Postal Code
380060
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ahmedabad
State/Province
Gujarat
ZIP/Postal Code
380060
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ahmedabad
State/Province
Gujarat
ZIP/Postal Code
38006
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Surat
State/Province
Gujarat
ZIP/Postal Code
395001
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Surat
State/Province
Gujarat
ZIP/Postal Code
395002
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vadodara
State/Province
Gujarat
ZIP/Postal Code
390022
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Gurugram
State/Province
Haryana
ZIP/Postal Code
122001
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangalore
State/Province
Karnataka
ZIP/Postal Code
560017
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cochin
State/Province
Kerala
ZIP/Postal Code
682041
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kochi
State/Province
Kerala
ZIP/Postal Code
682018
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kozhikode
State/Province
Kerala
ZIP/Postal Code
673008
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mumbai
State/Province
Maharashtra
ZIP/Postal Code
400012
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nagpur
State/Province
Maharashtra
ZIP/Postal Code
440003
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nagpur
State/Province
Maharashtra
ZIP/Postal Code
440010
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nagpur
State/Province
Maharashtra
ZIP/Postal Code
440012
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pune
State/Province
Maharashtra
ZIP/Postal Code
411001
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pune
State/Province
Maharashtra
ZIP/Postal Code
411004
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pune
State/Province
Maharashtra
ZIP/Postal Code
411011
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Dehli
State/Province
New Delhi
ZIP/Postal Code
110029
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chandigarh
State/Province
Punjab
ZIP/Postal Code
160012
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ludhiana
State/Province
Punjab
ZIP/Postal Code
141001
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ludhiana
State/Province
Punjab
ZIP/Postal Code
141002
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mohali
State/Province
Punjab
ZIP/Postal Code
160062
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jaipur
State/Province
Rajasthan
ZIP/Postal Code
302001
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jodhpur
State/Province
Rajasthan
ZIP/Postal Code
342005
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chennai
State/Province
Tamil Nadu
ZIP/Postal Code
600037
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hyderbad
State/Province
Telengana
ZIP/Postal Code
500 012
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lucknow
State/Province
Uttar Pradesh
ZIP/Postal Code
226003
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dehradun
State/Province
Uttarakhand
ZIP/Postal Code
248001
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aligarh
ZIP/Postal Code
202002
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bengaluru
ZIP/Postal Code
560054
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Karnataka
ZIP/Postal Code
590010
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kolkata
ZIP/Postal Code
700020
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Delhi
ZIP/Postal Code
110025
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Delhi
ZIP/Postal Code
110055
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Delhi
ZIP/Postal Code
110060
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Delhi
ZIP/Postal Code
110075
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Palakkad
ZIP/Postal Code
678013
Country
India
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Puducherry
ZIP/Postal Code
605006
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
State/Province
Leinster
ZIP/Postal Code
D08 A978
Country
Ireland
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Cork
ZIP/Postal Code
T12 DC4A
Country
Ireland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
ZIP/Postal Code
A96 D628
Country
Ireland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
ZIP/Postal Code
D07 KX5K
Country
Ireland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
ZIP/Postal Code
D07KWR1
Country
Ireland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mahon, Cork
ZIP/Postal Code
T12 K199
Country
Ireland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Haifa
ZIP/Postal Code
3109601
Country
Israel
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jerusalem
ZIP/Postal Code
91120
Country
Israel
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Petah-Tikva
ZIP/Postal Code
49100
Country
Israel
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rehovot
ZIP/Postal Code
7661041
Country
Israel
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tel Aviv
ZIP/Postal Code
6423906
Country
Israel
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tel Hashomer
ZIP/Postal Code
5265601
Country
Israel
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zrifin
ZIP/Postal Code
70300
Country
Israel
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Casale Monferrato
State/Province
Al
ZIP/Postal Code
15033
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bergamo
State/Province
Bg
ZIP/Postal Code
24127
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Benevento
State/Province
Bn
ZIP/Postal Code
82100
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Brescia
State/Province
Bs
ZIP/Postal Code
25123
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Caserta
State/Province
Ce
ZIP/Postal Code
81100
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Catanzaro
State/Province
Cz
ZIP/Postal Code
88100
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Catanzaro
State/Province
Cz
ZIP/Postal Code
88100
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cona (Ferrara)
State/Province
Fe
ZIP/Postal Code
44124
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Genova
State/Province
Ge
ZIP/Postal Code
16132
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Perugia
State/Province
Pg
ZIP/Postal Code
06129
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pisa
State/Province
Pi
ZIP/Postal Code
56124
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pisa
State/Province
Pi
ZIP/Postal Code
56126
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Roma
State/Province
Rm
ZIP/Postal Code
00135
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Siena
State/Province
Si
ZIP/Postal Code
53100
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rivoli
State/Province
To
ZIP/Postal Code
10098
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Torino
State/Province
To
ZIP/Postal Code
10128
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Torino
State/Province
To
ZIP/Postal Code
10128
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Verona
State/Province
Vr
ZIP/Postal Code
37126
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Verona
State/Province
Vr
ZIP/Postal Code
37126
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Foggia
ZIP/Postal Code
71122
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Napoli
ZIP/Postal Code
80131
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Novara
ZIP/Postal Code
28100
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pavia
ZIP/Postal Code
27100
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pavia
ZIP/Postal Code
27100
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Trieste
ZIP/Postal Code
34128
Country
Italy
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Trieste
ZIP/Postal Code
34128
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Uwajima-shi, Ehime
State/Province
Ehime, Uwajima-shi
ZIP/Postal Code
798-8510
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Yokohama
State/Province
Kanagawa
ZIP/Postal Code
227-8501
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bunkyo-ku, Tokyo
ZIP/Postal Code
113-8655
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Fukuoka
ZIP/Postal Code
810-8539
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Fukuoka
ZIP/Postal Code
812-8582
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Himeji-shi, Hyogo
ZIP/Postal Code
670-8560
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hokkaido
ZIP/Postal Code
078-8211
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hyogo
ZIP/Postal Code
665-0125
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ibaraki
ZIP/Postal Code
311-3193
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Imabari-shi, Ehime
ZIP/Postal Code
799-1592
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ishikawa
ZIP/Postal Code
920-8530
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ishikawa
ZIP/Postal Code
920-8530
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kagawa
ZIP/Postal Code
769-1695
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kagoshima
ZIP/Postal Code
890-8760
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kanagawa
ZIP/Postal Code
236-0037
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kanagawa
ZIP/Postal Code
236-0051
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kishiwada-shi, Osaka
ZIP/Postal Code
596-0042
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kitakyushu-shi, Fukuoka
ZIP/Postal Code
806-8501
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kyoto
ZIP/Postal Code
604-8401
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kyoto
ZIP/Postal Code
606-8507
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mie
ZIP/Postal Code
510-8561
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Miyagi
ZIP/Postal Code
980-0803
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Miyagi
ZIP/Postal Code
983-8512
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Miyagi
ZIP/Postal Code
983-8520
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Morioka-shi, Iwate
ZIP/Postal Code
020-0066
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nagasaki
ZIP/Postal Code
850-8555
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Okayama-shi, Okayama
ZIP/Postal Code
700-8558
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Okayama
ZIP/Postal Code
700-8557
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Okayama
ZIP/Postal Code
701-1154
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
540-0006
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
564-0013
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
564-8565
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
565-0871
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
581-0011
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saga
ZIP/Postal Code
840-8571
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shizuoka
ZIP/Postal Code
436-8555
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Takamatsu-shi, Kagawa
ZIP/Postal Code
760-8557
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tokyo
ZIP/Postal Code
103-0027
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tokyo
ZIP/Postal Code
140-8522
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tottori
ZIP/Postal Code
683-8504
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Toyama
ZIP/Postal Code
930-0194
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Yamaguchi
ZIP/Postal Code
740-8510
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Yamaguchi
ZIP/Postal Code
745-8522
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Yokohama-shi, Kanagawa
ZIP/Postal Code
234-0054
Country
Japan
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Busan
ZIP/Postal Code
49241
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cheongju
ZIP/Postal Code
28644
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Gwangju
ZIP/Postal Code
61469
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Gyeonggi-do
ZIP/Postal Code
13620
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Incheon
ZIP/Postal Code
21565
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seoul
ZIP/Postal Code
03080
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seoul
ZIP/Postal Code
03722
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seoul
ZIP/Postal Code
06351
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seoul
ZIP/Postal Code
08308
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wonju
ZIP/Postal Code
26426
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Riga
ZIP/Postal Code
LV-1001
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Riga
ZIP/Postal Code
LV-1002
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Riga
ZIP/Postal Code
LV-1023
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Riga
ZIP/Postal Code
LV-1079
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Riga
ZIP/Postal Code
LV1011
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kaunas
ZIP/Postal Code
49449
Country
Lithuania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kaunas
ZIP/Postal Code
LT-49387
Country
Lithuania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Klaipeda
ZIP/Postal Code
LT-92288
Country
Lithuania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Siauliai
ZIP/Postal Code
LT-76206
Country
Lithuania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vilnius
ZIP/Postal Code
LT-08406
Country
Lithuania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Vilnius
ZIP/Postal Code
LT-08661
Country
Lithuania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kota Bharu
State/Province
Kelantan
ZIP/Postal Code
16150
Country
Malaysia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cheras
State/Province
Kuala Lumpur
ZIP/Postal Code
56000
Country
Malaysia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cheras
State/Province
Kuala Lumpur
ZIP/Postal Code
56000
Country
Malaysia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kota Samarahan
State/Province
Sarawak
ZIP/Postal Code
94300
Country
Malaysia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sungai Buloh
State/Province
Selangor
ZIP/Postal Code
47000
Country
Malaysia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Alor Setar
ZIP/Postal Code
05460
Country
Malaysia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kuala Lumpur
ZIP/Postal Code
59100
Country
Malaysia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kuantan
ZIP/Postal Code
25100
Country
Malaysia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aguascalientes
State/Province
Ags
ZIP/Postal Code
20230
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aguascalientes
State/Province
Ags
ZIP/Postal Code
20230
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tijuana
State/Province
Baja California
ZIP/Postal Code
22500
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
44130
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ciudad de Mexico
State/Province
México, D.F.
ZIP/Postal Code
14080
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
San Nicolas de los Garza
State/Province
NL
ZIP/Postal Code
66465
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Monterrey
State/Province
Nuevo Leon
ZIP/Postal Code
64060
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Monterrey
State/Province
Nuevo Leon
ZIP/Postal Code
64060
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Monterrey
State/Province
Nuevo Leon
ZIP/Postal Code
64718
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Monterrey
State/Province
Nuevo León
ZIP/Postal Code
64020
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Santiago De Querétaro, Qro.
State/Province
Querétaro
ZIP/Postal Code
76000
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Santiago De Querétaro, Qro.
State/Province
Querétaro
ZIP/Postal Code
76000
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
San Luis Potosí
State/Province
San Luis Potosi
ZIP/Postal Code
78200
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Culiacán
State/Province
Sinaloa
ZIP/Postal Code
80230
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Xalapa
State/Province
Veracruz
ZIP/Postal Code
91193
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Xalapa
State/Province
Veracruz
ZIP/Postal Code
91193
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mexico City
ZIP/Postal Code
03100
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Den Haag
ZIP/Postal Code
2545AA
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Deventer
ZIP/Postal Code
7416 SE
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dordrecht
ZIP/Postal Code
3318 AT
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Emmen
ZIP/Postal Code
7824 AA
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Enschede
ZIP/Postal Code
7512 KZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Groningen
ZIP/Postal Code
9713 GZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Heerlen
ZIP/Postal Code
6419 PC
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Maastricht
ZIP/Postal Code
6229 HX
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nijmegen
ZIP/Postal Code
6525 GA
Country
Netherlands
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Rotterdam
ZIP/Postal Code
3015 GD
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Skopje
ZIP/Postal Code
1000
Country
North Macedonia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bergen
ZIP/Postal Code
5021
Country
Norway
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lørenskog
ZIP/Postal Code
1478
Country
Norway
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Oslo
ZIP/Postal Code
0372
Country
Norway
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Oslo
ZIP/Postal Code
0450
Country
Norway
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Stavanger
ZIP/Postal Code
NO-4011
Country
Norway
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wroclaw
State/Province
Dolnoslaskie
ZIP/Postal Code
50-556
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wroclaw
State/Province
Dolnoslaskie
ZIP/Postal Code
51-134
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wroclaw
State/Province
Dolnoslaskie
ZIP/Postal Code
53-114
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Włocławek
State/Province
Kujawsko-pomorskie
ZIP/Postal Code
87-800
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Torun
State/Province
Kuyavian-Pomeranian Voivodeship
ZIP/Postal Code
87-100
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Belchatow
State/Province
Lodzkie
ZIP/Postal Code
97-400
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lodz
State/Province
Lodzkie
ZIP/Postal Code
90-549
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Warszawa
State/Province
Mazowieckie
ZIP/Postal Code
00-416
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chrzanów
State/Province
Małopolskie
ZIP/Postal Code
32-500
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cracow
State/Province
Małopolskie
ZIP/Postal Code
30-701
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cracow
State/Province
Małopolskie
ZIP/Postal Code
30-701
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bialystok
State/Province
Podlaskie Voivodeship
ZIP/Postal Code
15-111
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bialystok
State/Province
Podlaskie
ZIP/Postal Code
15-276
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Katowice
State/Province
Silesian Voivodeship
ZIP/Postal Code
40-635
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ruda Slaska
State/Province
Silesian Voivodeship
ZIP/Postal Code
41-710
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zabrze
State/Province
Slaskie
ZIP/Postal Code
41-800
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Belchatow
ZIP/Postal Code
97-400
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Gdynia
ZIP/Postal Code
81-157
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Grodzisk Mazowiecki
ZIP/Postal Code
05-825
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Krakow
ZIP/Postal Code
30-082
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Krakow
ZIP/Postal Code
31-271
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lodz
ZIP/Postal Code
91-347
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lodz
ZIP/Postal Code
93-338
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Przemysl
ZIP/Postal Code
37-700
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sztum
ZIP/Postal Code
82-400
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Warszawa
ZIP/Postal Code
04-141
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zgierz
State/Province
Łódź Voivodeship
ZIP/Postal Code
95-100
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dąbrowa Górnicza
State/Province
Śląskie
ZIP/Postal Code
41-300
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Katowice
State/Province
Śląskie
ZIP/Postal Code
40-648
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tychy
State/Province
Śląskie
ZIP/Postal Code
43-100
Country
Poland
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Guilhufe - Penafiel
ZIP/Postal Code
4560-136
Country
Portugal
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lisboa
ZIP/Postal Code
1500-650
Country
Portugal
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lisboa
ZIP/Postal Code
1649-035
Country
Portugal
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lisbon
ZIP/Postal Code
1449-005
Country
Portugal
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Porto
ZIP/Postal Code
4099-001
Country
Portugal
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Setubal
ZIP/Postal Code
2910-446
Country
Portugal
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cluj Napoca
State/Province
Cluj
ZIP/Postal Code
400015
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tirgu Mures
State/Province
Targu Mures
ZIP/Postal Code
540143
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Baia Mare
ZIP/Postal Code
430222
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Braila
ZIP/Postal Code
810325
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Brasov
ZIP/Postal Code
500283
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucharest
ZIP/Postal Code
021875
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
011053
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
011461
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
012292
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
014146
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
020339
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
021337
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
042122
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bucuresti
ZIP/Postal Code
050098
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Buzau
ZIP/Postal Code
120133
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Constanta
ZIP/Postal Code
900591
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Craiova
ZIP/Postal Code
200383
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Craiova
ZIP/Postal Code
200513
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Iasi
ZIP/Postal Code
700503
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Iasi
ZIP/Postal Code
700547
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Iasi
ZIP/Postal Code
700732
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pascani
ZIP/Postal Code
705200
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pitesti
ZIP/Postal Code
110424
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Targu Mures
ZIP/Postal Code
540136
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Timisoara
ZIP/Postal Code
300310
Country
Romania
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Timișoara
ZIP/Postal Code
300254
Country
Romania
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Belgrade
ZIP/Postal Code
11000
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Belgrade
ZIP/Postal Code
11000
Country
Serbia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Belgrade
ZIP/Postal Code
11080
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Belgrade
ZIP/Postal Code
11080
Country
Serbia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kragujevac
ZIP/Postal Code
34000
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nis
ZIP/Postal Code
18108
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sremska Kamenica
ZIP/Postal Code
21204
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Singapore
ZIP/Postal Code
119074
Country
Singapore
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Singapore
ZIP/Postal Code
169609
Country
Singapore
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Singapore
ZIP/Postal Code
529889
Country
Singapore
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Singapore
ZIP/Postal Code
544886
Country
Singapore
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Singapore
ZIP/Postal Code
768828
Country
Singapore
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Brezno
State/Province
Banskobystricky Kraj
ZIP/Postal Code
977 01
Country
Slovakia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Svidnik
State/Province
Presovsky Kraj
ZIP/Postal Code
089 01
Country
Slovakia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bratislava
ZIP/Postal Code
84108
Country
Slovakia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kosice
ZIP/Postal Code
040 22
Country
Slovakia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nitra
ZIP/Postal Code
949 01
Country
Slovakia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Trnava
ZIP/Postal Code
917 02
Country
Slovakia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Zilina
ZIP/Postal Code
010 01
Country
Slovakia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Celje
ZIP/Postal Code
SI-3000
Country
Slovenia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ljubljana
ZIP/Postal Code
SI-1000
Country
Slovenia
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Maribor
ZIP/Postal Code
SI-2000
Country
Slovenia
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
George
State/Province
Eastern Cape
ZIP/Postal Code
6529
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bloemfontein
State/Province
Free State
ZIP/Postal Code
9301
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Centurion
State/Province
Gauteng
ZIP/Postal Code
0157
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Johannesburg
State/Province
Gauteng
ZIP/Postal Code
2013
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Johannesburg
State/Province
Gauteng
ZIP/Postal Code
2192
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Johannesburg
State/Province
Gauteng
ZIP/Postal Code
2193
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lenasia
State/Province
Gauteng
ZIP/Postal Code
1827
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0002
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0083
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0157
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
0184
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Durban
State/Province
KwwaZulu Natal
ZIP/Postal Code
4300
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cape Town
State/Province
Western Cape
ZIP/Postal Code
7130
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cape Town
State/Province
Western Cape
ZIP/Postal Code
7500
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cape Town
State/Province
Western Cape
ZIP/Postal Code
7500
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cape Town
State/Province
Western Cape
ZIP/Postal Code
7530
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Cape Town
State/Province
Western Cape
ZIP/Postal Code
7935
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mossel Bay
State/Province
Western Cape
ZIP/Postal Code
6506
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Worcester
State/Province
Western Cape
ZIP/Postal Code
6850
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Badalona
State/Province
Barcelona
ZIP/Postal Code
08916
Country
Spain
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
L'Hospitalet de Llobregat
State/Province
Barcelona
ZIP/Postal Code
08907
Country
Spain
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Las Palmas de Gran Canaria
ZIP/Postal Code
35019
Country
Spain
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Madrid
ZIP/Postal Code
28034
Country
Spain
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Madrid
ZIP/Postal Code
28040
Country
Spain
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Madrid
ZIP/Postal Code
28222
Country
Spain
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sevilla
ZIP/Postal Code
41003
Country
Spain
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kaohsiung city
ZIP/Postal Code
807
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Taichung City
ZIP/Postal Code
407
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Taipei city
ZIP/Postal Code
110
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Taipei
ZIP/Postal Code
112
Country
Taiwan
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Taipei
ZIP/Postal Code
112
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Taoyuan city
ZIP/Postal Code
333
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Klong Luang, Pathumthani
State/Province
Pathumthani
ZIP/Postal Code
12120
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hat Yai
State/Province
Songkla
ZIP/Postal Code
90110
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10210
Country
Thailand
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10300
Country
Thailand
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10300
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10700
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chiang Mai
ZIP/Postal Code
50200
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chiang Mai
ZIP/Postal Code
50200
Country
Thailand
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Khon Kaen
ZIP/Postal Code
40002
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ubon Ratchathani
ZIP/Postal Code
34000
Country
Thailand
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Afyon
ZIP/Postal Code
03200
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ankara
ZIP/Postal Code
06230
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Antalya
ZIP/Postal Code
07059
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Edirne
ZIP/Postal Code
22030
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Eskisehir
ZIP/Postal Code
26040
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Istanbul
ZIP/Postal Code
34303
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Istanbul
ZIP/Postal Code
34668
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Izmir
ZIP/Postal Code
35100
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Izmir
ZIP/Postal Code
35340
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kayseri
ZIP/Postal Code
38039
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kocaeli
ZIP/Postal Code
41380
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mersin
ZIP/Postal Code
33343
Country
Turkey
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Basildon
State/Province
Essex
ZIP/Postal Code
SS16 5NL
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Airdrie
State/Province
Lanarkshire
ZIP/Postal Code
ML6 0JS
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Tooting
State/Province
London
ZIP/Postal Code
SW17 0RE
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
East Kilbride
State/Province
South Lanarkshire
ZIP/Postal Code
G74 8RG
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chichester
State/Province
West Sussex
ZIP/Postal Code
PO19 6SE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aberdeen
ZIP/Postal Code
AB25 2ZN
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bristol
ZIP/Postal Code
BS10 5NB
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Craigavon
ZIP/Postal Code
BT63 5QQ
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dorest
ZIP/Postal Code
BH7 7DW
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Exeter
ZIP/Postal Code
EX2 5DW
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Glasgow
ZIP/Postal Code
G31 2ER
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
High Wycombe
ZIP/Postal Code
HP11 2TT
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Liverpool
ZIP/Postal Code
L9 7AL
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Manchester
ZIP/Postal Code
M13 9WL
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
North Shields
ZIP/Postal Code
NE29 8NH
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Oxford
ZIP/Postal Code
OX3 9DU
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Stockton-on-Tees
ZIP/Postal Code
TS19 8PE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Stockton-on-Tees
ZIP/Postal Code
TS19 8PE
Country
United Kingdom
Individual Site Status
Not yet recruiting

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
According to the Novo Nordisk disclosure commitment on novonordisk-trials.com
IPD Sharing URL
http://novonordisk-trials.com

Learn more about this trial

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

We'll reach out to this number within 24 hrs